Big Automation, Targeted Application: Advanced Aseptic Solutions for a Smaller Footprint
One of the benefits of the increasing adoption of robotics and automation for fill-finish processing is that with growth comes standardization and accessibility. There has
A Closer Look at the New Annex 1: What’s included and What It Means for the Fill-Finish Industry
With the revised Annex 1 coming into effect last year, the pharmaceutical industry continues to strategize the best way to attain and maintain compliance with
AST Revolutionizes Fill-Finish: American Pharmaceutical Review’s interview with Josh Russell
Josh Russell, Vice President of Sales and Marketing, recently spoke to American Pharmaceutical Review on AST’s latest aseptic processing solutions. American Pharmaceutical Review, a leading
Highlighting Innovation: A Video Breakdown of AST’s New Fill-Finish Isolator
AST’s Director of Engineering Spencer Bolte walks through some of the key design considerations on AST’s new isolator including operator-centered solutions and a groundbreaking new
The GENiSYS® C: Precision Automation, Intuitive Simplicity
For pharmaceutical manufacturers, every endeavor into drug development comes with a measure of uncertainty and unpredictability. It’s important to have a plan in place for
Live from New York: Debuting a 100 % AST Turnkey Solution
The AST team recently returned from New York City, the site of Interphex 2024, and to say we came back motivated would be an understatement.
The Future of CDMOs: Aseptic Solutions for Growth and Innovation
When deciding on an aseptic fill/finish machine, the choice to use a gloved or gloveless isolator will arise – and we want to help with that decision. There are a few attributes to consider when choosing between a gloved or a gloveless isolator.
AST Partnership with Quality Chemical Laboratories
We are proud to announce our partnership with QCL on both a GENiSYS® C and GENiSYS® R